Zydus Lifesciences completes 50:50 JV transaction with Sunshine Healthcare Lanka

In a significant strategic move, Zydus Lifesciences Ltd has secured a 50 percent interest in Zydus Sunshine Lifesciences Pvt Ltd, forging a joint venture with Sunshine Healthcare Lanka Limited. This partnership was concluded on November 11, 2026, following a timeline extension that pushed the original closing date from June 26, 2026, to December 2026.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/T4xhX38
via IFTTT